Functional genomics studies, despite increasingly varied assay types and complex experimental designs, are typically analyzed by methods that are unable to identify confounding effects and that incorporate parametric assumptions particular to gene expression data. We present MAVRIC, a nonparametric method to quantify variance explained by experimental covariates and perform differential analysis on arbitrary data types. We demonstrate that MAVRIC can accurately associate covariates with underlying data variance, deliver sensitive and specific identification of genomic loci with differential counts, and provide effective noise reduction of large-scale consortium data sets.
The ATAC-seq data cataloged chromatin accessibility in naive, central memory, and effector memory human CD8 T cells, and we applied both MAVRIC and DESeq2 to identify loci more accessible in the effector memory than the central memory cells. We found that MAVRIC recapitulated the majority of the significant results from DESeq2, while identifying substantially more changes overall (Fig. 2c) . We next calculated sequence enrichment for transcription factor binding motifs in each of three sets of loci identified as differentially accessible: unique to MAVRIC (purple circle , Fig. 2c ); unique to DESeq2 (green circle , Fig. 2c ); and overlapping (brown circle, Fig. 2c ), which we considered a gold standard ( Supplementary Fig. 2b) . We compared the gold-standard motif enrichment p-values to those of the two other sets and observed that motif enrichment p-values for MAVRIC exhibited a significantly higher area under the receiver operating characteristic curve (AUC) than did the p-values for DESeq2 (Fig. 2d) . Gene ontology enrichment of the differentially accessible peaks also showed high concordance between the results for the overlapping peaks and the peaks unique to MAVRIC, while the peaks unique to DESeq2 produced no statistically significant categories ( Supplementary Fig. 2c ).
Next, we applied MAVRIC to large-scale consortium data, to test its effectiveness at distinguishing biological signal from the noise of experimental heterogeneity of data generated by multiple investigators at different institutions. Using RNA-seq data of 29 human tissues from the GTEx project, which aims to connect tissue-specific gene expression levels to expression quantitative trait loci (eQTLs) 19 , we found that correlating samples based on raw counts and applying k-means partially separated the samples by tissue (Fig. 3a) . Repeating this analysis on counts adjusted by sva 11, 20 , to correct for latent factors affecting the expression measurements and identify differentially expressed genes, we observed that the clustering more accurately reflected tissue types, while reducing the total data variance by 9.6% (Fig. 3b) . When we instead applied MAVRIC to the counts, to select for high-variance features and PCs associated with the tissue covariate, we determined that the clustering improved more than with sva, while reducing variance by 10.4% relative to the raw data (Fig. 3c) . The high-variance genes identified by MAVRIC were also more likely to be differentially affected by eQTLs across tissues than were the top differentially expressed genes identified by sva's workflow (see Methods, Supplementary fig. 3 ). Thus, compared to sva, MAVRIC offered a data correction that provided superior clarity of the biological differences of interest, while retaining a similar fraction of total variance.
By associating PCs with experimental covariates, MAVRIC can identify sources of variance, perform differential analysis, and reduce artifactual variation, without requiring that the user make explicit assumptions about which covariates are impactful. By focusing on data visualization, MAVRIC's outputs maximize interpretability, providing users with a comprehensive overview of the biological and technical effects captured by functional genomics experiments. We expect that MAVRIC will provide a valuable complement to gene expression-oriented methods, particularly for use with newer assay types and in more expansive experimental designs. (1) input a data matrix and a covariate matrix, (2) optionally normalize data and select high-variance features, (3) perform PCA, (4) associate PCs with covariates to quantify contributions to variance, and (5) define "axes of variance" for differential analysis. (b) Top three PCs identified by MAVRIC as associated with species-specific and tissue-specific effects in previously published RNA-seq data 15 . Next three PCs depicted in Supplementary Fig. 1d . . MAVRIC then obtains a p-value for the observed average silhouette by permuting the coordinates 10,000 times and recalculating the average silhouette, forming a null distribution. The p-value of the observed average silhouette with respect to the null distribution tests the hypothesis that the PC offers a coordinate space in which the categories are segregated more than expected by chance. When more than one PC exhibits a significant p-value (based on a user-specified alpha), MAVRIC selects the single PC for which the difference between the observed average silhouette and the expected average silhouette is maximal, where the expected average silhouette is the mean of the null distribution.
Figures and legends
(b) PCs beyond the first are added to a covariate's association subspace by forward selection. In particular, during the permutations, only the newly added PC's coordinates are permuted, while those that MAVRIC has already associated with the covariate remain constant. Thus, the p-value tests the hypothesis that adding another PC to the current subspace improves the segregation between the categories more than expected by chance. (c) MAVRIC performs differential analysis by defining an "axis of variance" for a particular pairwise comparison between categories. The axis of variance is the line given by the two categories' respective centroids in the subspace of associated PCs. Each sample's coordinate in the associated PC subspace is projected onto that axis, yielding a univariate point for every sample in the data set. These projected values are then correlated with the values from the original data matrix. A high absolute correlation indicates that the variance for a feature aligns with the variance between the two categories, and thus that that feature is differentially expressed.
(d) Fourth-through sixth-ranked PCs identified by MAVRIC as associated with tissue-specific effects in previously published RNA-seq data 15 . ... 
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Sample 1 Sample 2 17 3 Feat. 1 Feat. 2 ... 21 6 ... Fig. 2c ). The results are concordant with those of the original study 18 , and were thus used as a gold standard. (c) Gene ontology (GO) enrichment for peaks identified as differentially accessible by both MAVRIC and DESeq2 (x-axis; brown circle, Fig. 2c ), versus GO enrichment for peaks identified as differentially accessible only by MAVRIC (y-axis; purple circle, Fig. 2c ). Each point represents a GO category that was significantly enriched in at least one of the two peak sets at an alpha of .05 after multiple hypothesis correction. Pearson correlation = 0.70. The peaks identified as differentially accessible only by DESeq2 did not produce any significantly enriched GO categories.
Supplementary Figure 3 : Representation of genes affected by eQTLs following correction of GTEx data by sva versus by MAVRIC (a) Odds ratios for likelihood that a selected gene had expression affected by an eQTL, for MAVRIC (left) and sva (right), as compared to all genes in the GTEx data set 19 . For MAVRIC, selected genes are those identified by its feature selection workflow as having high variance (see Methods). For sva, selected genes are an equal number of the top genes (as measured by smallest p-value) with significantly differential expression across tissues following data correction (see Methods). (b) Distributions of numbers of tissues in which gene expression is affected by an eQTL. Sets of genes used for MAVRIC (purple) and sva (gold) are as in (a). Dotted black line gives distribution across all genes in the GTEx data.
Methods

Inputs to MAVRIC
MAVRIC has two required inputs, a data matrix and a design matrix (Fig. 1a) . The data matrix is of dimension P x N, for P features measured across N samples. For RNA-seq, the features would represent genes; for ChIP-seq or ATAC-seq, the features would represent peaks. The design matrix is of dimension N x M, for M covariates annotated across the same set of samples. The covariates reflect biological and technical attributes of the sample (e.g. treatment, sex, RIN), and can represent either categorial or continuous variables. MAVRIC requires that each categorical covariate has at least two categories, and that each category has at least two samples.
Data preprocessing in MAVRIC
The data matrix is optionally initially processed with a variance-stabilizing transformation to reduce heteroskedasticity, thereby likewise reducing the extent to which features with high means act as the primary drivers of the directions of the PC vectors. To avoid any parametric assumptions, the logarithm can be applied, or the user can employ a normalization with parametric assumptions particular to RNAseq. Next, MAVRIC attempts to improve statistical power by eliminating features with low variance, which are unlikely to be differential. For the feature selection process, MAVRIC fits, to the mean versus variance trend, an iteratively reweighted loess function, with weights given by a redescending M-estimator (Tukey's biweight) based on the residuals. For point i with residual r(i), the weight w(i) is:
The constant k controls robustness and here is set to the typical value of 4.685, which provides desirable asymptotic efficiency. Thus, features with high residuals are assigned lower weights, yielding a fit where high-variance features have low statistical leverage. Features with variance above the 95% confidence interval of the loess fit are considered to have higher than expected variance given their means; the remaining features are discarded.
The normalization and feature selection steps described above are both optional and flexible: The user is also able to normalize the data prior to inputting it to MAVRIC, and may further decide whether or not to employ a variance-stabilizing transformation. For feature selection, the user has the option of specifying that MAVRIC retain the v features with the highest variance (after normalization), rather than using the loess fit to control for any residual mean/variance dependence.
Using MAVRIC to associate PCs with experimental covariates
On the normalized data matrix, MAVRIC performs PCA, and then iterates over the covariates in the design matrix, associating each covariate with a subset of the PCs. Certain PCs are discarded at the outset, according to a user-specified eigenvalue threshold: Any PC that explains less variance than the threshold is discarded without evaluating its associations with the covariates.
For categorical covariates, MAVRIC uses forward selection to establish the maximal set of PCs for which the spatial separation between the categories is greater than expected by chance. The use of forward selection helps reduce average run-time, particularly for large-scale consortium data with many samples, because the majority of PCs are generally expected to correspond to inter-sample differences and stochastic variability, with only a small number of PCs attributable to variance associated with each covariate. In the forward selection workflow, for each PC, the silhouette statistic 21 , averaged across all samples, is used to quantify the separation between the categories. For a sample i in category A, the silhouette, s(i), assesses how close i is to the others in its category, relative to the samples in the spatially nearest category: distance(i,j) refers to the Euclidean distance between points i and j in the current PC subspace. The observed average silhouette is compared against the null distribution generated by average silhouette statistics calculated on 10,000 permutations of the PC coordinates. If there is a PC for which the one-sided p-value for the observed average silhouette is significant, that PC is considered to be associated with the covariate; if there is more than one such PC, only the single PC with the greatest difference between the observed average silhouette and the expected average silhouette is taken. The process then repeats on the remaining PCs, with null distributions calculated by permuting only the newly added coordinates, to test whether adding that dimension to the current PC subspace improves the separation more than expected by chance, given the current subspace. When there are no further PCs that can be added to improve the separation, the process ends, and the next covariate is considered.
For continuous covariates, significant associations are established using the lasso. The lasso is not likewise used with categorical covariates for compatibility with the small sample sizes characteristic of sequencing experiments. In the lasso, For responses y and PC coordinates X, the regression coefficients, β, are given by:
The regularization parameter, λ, is determined by cross-validation. The number of folds in the crossvalidation is set such that there are at least three samples in each fold, up to a maximum of 10 folds. When fewer than 15 samples are supplied, leave-one-out cross-validation is employed.
Estimating covariates' contributions to data variance with MAVRIC
Using the associations between PCs and covariates, MAVRIC calculates each covariate's contribution to the total data variance. To determine contributions to variance, MAVRIC calculates a weighted sum of eigenvalues for each covariate, where the eigenvalues are those that correspond to the PC vectors. For PCs associated with the covariate, the weight is the within-group sum-of-squares (WGSS) divided by the total sum-of-squares (TSS), within that PC coordinate's subspace; for PCs not associated with the covariate, the weight is 0. The contribution to variance V(A) for covariate A with categories C is as follows:
